Wednesday, June 10, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 42 of 1,261
  1. US 12303724

    Non-adult human dosing of anti-CD30 antibody-drug conjugates for treatment of hematological or lymphoid cancer

    Takeda Pharmaceutical Company Limited Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  2. US 12303602

    Compositions, methods and uses for thermally stable multi-targeted antigens

    The Regents of the University of Colorado, a Body Corporate Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  3. US 12304907

    Compounds and methods of use

    Tango Therapeutics, Inc. Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  4. US 12303551

    Cellular immunotherapy compositions and uses thereof

    Cero Therapeutics Holdings, Inc. Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  5. US 12304908

    Azabenzimidazoles and their use as AMPA receptor modulators

    Rapport Therapeutics, Inc. Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  6. US 12304969

    Factor XI A2 domain-binding antibodies and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  7. US 12304964

    CD38 modulating antibody

    BLACK BELT THERAPEUTICS LIMITED Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  8. US 12304930

    Prefusion-stabilized hMPV F proteins

    The Board of Regents of the University of Texas System Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  9. US 12295971

    Compositions and methods for enhancing adoptive T cell therapeutics

    The Regents of the University of California Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  10. US 12297431

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  11. US 12295941

    Viral inhibitors, the synthesis thereof, and intermediates thereto

    Takeda Pharmaceutical Company Limited Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  12. US 12295929

    Intravenous baclofen formulations and treatment methods

    Regents of the University of Minnesota Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  13. US 12296004

    Recombinant virus with diminished latency and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  14. US 12298319

    Method for measuring alpha value of muscarinic M1 receptor positive allosteric modulators

    Takeda Pharmaceutical Company Limited Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  15. US 12295394

    Water-soluble additive composition

    SUMITOMO BAKELITE CO., LTD. Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  16. US 12297241

    Method to engineer transplantable human tissues

    The Regents of the University of California Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  17. US 12297259

    Aspergillus antigen chimeric receptors and use thereof

    The Board of Regents of the University of Texas System Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  18. US 12297243

    Methods and compositions for reducing the immunogenicity of chimeric notch receptors

    Cell Design Labs, Inc. Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  19. US 12297452

    Methods or generating T-cells from stem cells and immunotherapeutic methods using the T-cells

    The Regents of the University of California Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  20. US 12295940

    Viral inhibitors, the synthesis thereof, and intermediates thereto

    Takeda Pharmaceutical Company Limited Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  21. US 12297209

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  22. US 12297257

    Multispecific antigen-binding molecules and uses thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  23. US 12296050

    Pharmaceutical compositions comprising maralixibat and uses thereof

    MIRUM PHARMACEUTICALS, INC. Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted
  24. US 12295362

    Formulations and processes for CAR T cell drug products

    Allogene Therapeutics, Inc. Β· Granted May 13, 2025 Β· Expires May 8, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.